Description
Amilar (Dequalinium Chloride) Lozenges №16
Ingredients
Active ingredient: Dequalinium chloride. Other ingredients may include sucrose, glucose, and flavors.
Mechanism of Action
Dequalinium chloride disrupts the cell membrane of microorganisms, leading to their death. This mechanism of action helps in clearing infections in the throat and mouth.
Pharmacological Properties
Dequalinium chloride has antiseptic properties that aid in reducing bacterial and fungal growth in the throat and mouth.
Indications for Use
Amilar lozenges are indicated for the relief of sore throat and mouth infections.
Contraindications
Do not use if allergic to any of the ingredients. Consult a healthcare professional before use if pregnant or breastfeeding.
Side Effects
No common side effects have been reported with the use of Amilar lozenges.
Usage Instructions
Adults and children over 6 years: Dissolve one lozenge slowly in the mouth every 2-3 hours as needed. Do not exceed 8 lozenges in 24 hours.
Place the lozenge in the mouth and allow it to dissolve slowly without chewing. Do not swallow whole.
Benefits Compared to Analogues
Amilar lozenges containing dequalinium chloride have shown to be more effective in reducing throat infections compared to placebo in clinical trials.
Suitable Patient Groups
Amilar lozenges are suitable for adults and children over 6 years of age. Consult a healthcare professional for children under 6 years of age.
Storage Conditions and Shelf Life
Store in a cool, dry place below 25°C. Keep out of reach of children. Do not use after the expiration date printed on the packaging.
Packaging Description
Amilar lozenges are available in a pack of 16 individually wrapped lozenges.
Clinical Evidence and Proven Effectiveness
Dequalinium chloride, the active ingredient in Amilar lozenges, has been clinically proven to effectively treat various oral infections and sore throats. A randomized controlled trial published in the Journal of Clinical Pharmacy and Therapeutics demonstrated the efficacy of dequalinium chloride lozenges in reducing throat infections compared to placebo.
